These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11825303)

  • 1. Antiplatelet therapy in secondary stroke prevention.
    Crawford KM; Talbert RL
    Expert Opin Pharmacother; 2001 Oct; 2(10):1609-13. PubMed ID: 11825303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents for stroke prevention.
    Paciaroni M; Gallai V
    Cerebrovasc Dis; 2000; 10 Suppl 4():36-9. PubMed ID: 11070399
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.
    Lenz T; Wilson A
    Clin Pharmacokinet; 2003; 42(10):909-20. PubMed ID: 12885264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer antiplatelet therapies in stroke prevention.
    Davis SM; Donnan GA
    Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
    Bhatt DL; Kapadia SR; Yadav JS; Topol EJ
    Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet agents in stroke prevention. combination therapy: present and future.
    Weksler BB
    Cerebrovasc Dis; 2000; 10 Suppl 5():41-8. PubMed ID: 11096182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Old and new platelet aggregation inhibitors: which to choose for prevention of stroke?].
    Devuyst G; Bogousslavsky J
    Rev Med Suisse Romande; 2000 Sep; 120(9):697-702. PubMed ID: 11094533
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of ischaemic stroke--antiplatelets.
    McCabe DJ; Brown MM
    Br Med Bull; 2000; 56(2):510-25. PubMed ID: 11092100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke.
    Redman AR; Ryan GJ
    Expert Opin Pharmacother; 2004 Jan; 5(1):117-23. PubMed ID: 14680441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clopidogrel in the prevention of stroke].
    Nagy V; Fehér J
    Orv Hetil; 2004 Dec; 145(51):2563-7. PubMed ID: 15715289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet agents for secondary prevention of ischemic stroke.
    Majid A; Delanty N; Kantor J
    Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy in cardiovascular disease.
    Behan MW; Storey RF
    Postgrad Med J; 2004 Mar; 80(941):155-64. PubMed ID: 15016937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
    Aw D; Sharma JC
    Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet agents in atherothrombotic diseases.
    Rao U; Weston C
    Hosp Med; 2004 Feb; 65(2):72-5. PubMed ID: 14997771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin should be first-line antiplatelet therapy in the secondary prevention of stroke.
    Warlow C
    Stroke; 2002 Aug; 33(8):2137-8. PubMed ID: 12154276
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE].
    Alvarez-Sabín J; Montaner-Villalonga J
    Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.